Dr. Robert E. Kalb, MD

Dr. Kalb practices at Upstate Dermatopathology in Buffalo, New York.

Dr. Kalb's NPI, 1750348454, was assigned on April 27, 2006. Dr. Kalb graduated from State University of New York Downstate Medical Center College of Medicine in 1982. Dr. Kalb holds New York license 157234-1.

Dr. Kalb's primary practice is Upstate Dermatopathology, at 6400 Sheridan Dr, Buffalo, NY 14221 in Erie County. The practice phone is (716) 334-0357.

Dr. Kalb's primary practice is Upstate Dermatopathology in Buffalo, New York. The medical group on file is Buffalo Medical Group. Dmand AI also links Dr. Kalb to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalb practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kalb's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kalb is licensed in New York.

CMS data shows 1,446 Medicare services from Dr. Kalb across 16 procedure codes in 2024, for 472 Medicare patients. Medicare paid $90,877 for them. Every service was in an office.

CMS counts 472 Medicare patients who saw Dr. Kalb in 2024. The largest group is 75 to 84, with 197 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kalb's median patient age at 72, with 46% women.

In 2024, Dr. Kalb wrote 1,833 Medicare Part D claims for 830 patients. 79% of them were for generic drugs. CMS names the drug for 1,618 of them, across 43 drugs with 11 or more claims each, at $2,736,576 in total drug cost. In 2023, CMS named 1,985 claims across 47 drugs.

Dr. Kalb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 121 procedures of removal or shaving of skin growth by Dr. Kalb, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 22 papers to Dr. Kalb, published from 2007 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Psoriasis, Anti-Inflammatory Agents and Immunosuppressive Agents. Dr. Kalb has published most often in Am J Dermatopathol. Dr. Kalb's most frequent co-authors are Gerald G. Krueger, MD, Mark Gabriel Lebwohl and Joel M. Gelfand, MD.

Dmand AI links Dr. Kalb to 2 clinical trials. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. University of Pennsylvania sponsors the most, 2.

CMS Open Payments shows 278 general payments to Dr. Kalb from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Janssen Pharmaceuticals, Inc paid the most, $71,116. It also lists 7 research payments totaling $16,096 from 2016 to 2023.

Dr. Kalb graduated from State University of New York Downstate Medical Center College of Medicine in 1982.